Intravenously Delivered Mesenchymal Stem Cells: Systemic Anti-Inflammatory Effects Improve Left Ventricular Dysfunction in Acute Myocardial Infarction and Ischemic Cardiomyopathy.
about
Detection of intramyocardially injected DiR-labeled mesenchymal stem cells by optical and optoacoustic tomographyMesenchymal Stem Cell Therapy for the Treatment of Heart Failure Caused by Ischemic or Non-ischemic Cardiomyopathy: Immunosuppression and Its Implications.Improvement of therapeutic effects of mesenchymal stem cells in myocardial infarction through genetic suppression of microRNA-142.Cardiac Cell Therapy Evolving From Complex to Straightforward: Enabling Adoption and Affordability.Persistent Inflammation, Stem Cell-Induced Systemic Anti-Inflammatory Effects, and Need for Repeated Stem Cell Injections: Critical Concepts Influencing Optimal Stem Cell Strategies for Treating Acute Myocardial Infarction and Heart Failure.Exosomes and cardioprotection - A critical analysis.Dissecting the role of myeloid and mesenchymal fibroblasts in age-dependent cardiac fibrosis.Immunomodulation Is the Key to Cardiac Repair.Sequential intravenous allogeneic mesenchymal stromal cells as a potential treatment for thromboangiitis obliterans (Buerger's disease).Chaihulonggumulitang Shows Psycho-cardiology Therapeutic Effects on Acute Myocardial Infarction by Enhancing Bone Marrow Mesenchymal Stem Cells Mobilization.Granulocyte-Colony Stimulating Factor-Overexpressing Mesenchymal Stem Cells Exhibit Enhanced Immunomodulatory Actions Through the Recruitment of Suppressor Cells in Experimental Chagas Disease Cardiomyopathy.New Paradigms in Cell Therapy: Repeated Dosing, Intravenous Delivery, Immunomodulatory Actions, and New Cell TypesThe Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the Treatment of Immune-Related Diseases: A Systematic ReviewParallels between vertebrate cardiac and cutaneous wound healing and regeneration
P2860
Q30355871-E3BBBFD2-E24E-442E-937B-9708BBE0557CQ39223572-88A3F270-DFBD-4E68-A728-BAF726FA1A78Q47162014-A592DB20-3009-4139-951A-77886FDDB664Q49597231-BB0E80B6-5B34-4435-8AF6-FB50B2441159Q50027785-C4F18A5D-3E2F-4FE0-94FA-3C968E0D0F46Q50085056-067AA125-21BD-45BA-9B9B-CCE9F1A458F1Q50439185-07750BAC-7067-497B-AEAB-013EB9B57564Q52771193-AA562CCA-3B36-493C-801F-6D5F09728441Q55128876-16F8AE4C-3881-4446-8E72-66F1711AFC62Q55306317-7BC270A4-1A53-4E11-9BD4-1A4ED6CEC446Q55709087-2231B6FC-4618-40B9-B274-7F72996AA956Q57176906-50263D8A-9BB2-4168-826C-A9BE00B3DDB1Q57538743-99811458-F01F-4E7C-988D-7FB8556E52A1Q58699801-7E0F20D1-84B2-45AB-9638-E608EF0DEE56
P2860
Intravenously Delivered Mesenchymal Stem Cells: Systemic Anti-Inflammatory Effects Improve Left Ventricular Dysfunction in Acute Myocardial Infarction and Ischemic Cardiomyopathy.
description
2017 nî lūn-bûn
@nan
2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Intravenously Delivered Mesenc ...... n and Ischemic Cardiomyopathy.
@ast
Intravenously Delivered Mesenc ...... n and Ischemic Cardiomyopathy.
@en
type
label
Intravenously Delivered Mesenc ...... n and Ischemic Cardiomyopathy.
@ast
Intravenously Delivered Mesenc ...... n and Ischemic Cardiomyopathy.
@en
prefLabel
Intravenously Delivered Mesenc ...... n and Ischemic Cardiomyopathy.
@ast
Intravenously Delivered Mesenc ...... n and Ischemic Cardiomyopathy.
@en
P2093
P1433
P1476
Intravenously Delivered Mesenc ...... on and Ischemic Cardiomyopathy
@en
P2093
Alex Kharazi
David K Glover
Dror Luger
Grigory Vertelov
M Teresa Albelda
Michael J Lipinski
Peter C Westman
Ron Waksman
Sergey Sikora
Stephen E Epstein
P304
P356
10.1161/CIRCRESAHA.117.310599
P577
2017-02-23T00:00:00Z